Logo image of JBSS

JOHN B. SANFILIPPO & SON INC (JBSS) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:JBSS - US8004221078 - Common Stock

73.49 USD
-0.99 (-1.33%)
Last: 1/16/2026, 8:00:02 PM
73.49 USD
0 (0%)
After Hours: 1/16/2026, 8:00:02 PM
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to JBSS. JBSS was compared to 87 industry peers in the Food Products industry. JBSS has an average financial health and profitability rating. JBSS is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

  • In the past year JBSS was profitable.
  • In the past year JBSS had a positive cash flow from operations.
  • JBSS had positive earnings in each of the past 5 years.
  • Each year in the past 5 years JBSS had a positive operating cash flow.
JBSS Yearly Net Income VS EBIT VS OCF VS FCFJBSS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M 100M

1.2 Ratios

  • The Return On Assets of JBSS (11.02%) is better than 95.40% of its industry peers.
  • With an excellent Return On Equity value of 18.19%, JBSS belongs to the best of the industry, outperforming 90.80% of the companies in the same industry.
  • JBSS has a better Return On Invested Capital (13.93%) than 91.95% of its industry peers.
  • JBSS had an Average Return On Invested Capital over the past 3 years of 16.04%. This is significantly below the industry average of 27.80%.
Industry RankSector Rank
ROA 11.02%
ROE 18.19%
ROIC 13.93%
ROA(3y)12.11%
ROA(5y)13.03%
ROE(3y)18.85%
ROE(5y)20.67%
ROIC(3y)16.04%
ROIC(5y)17.32%
JBSS Yearly ROA, ROE, ROICJBSS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20

1.3 Margins

  • JBSS has a Profit Margin of 5.84%. This is in the better half of the industry: JBSS outperforms 75.86% of its industry peers.
  • In the last couple of years the Profit Margin of JBSS has declined.
  • The Operating Margin of JBSS (8.38%) is better than 72.41% of its industry peers.
  • JBSS's Operating Margin has declined in the last couple of years.
  • JBSS has a Gross Margin (18.68%) which is comparable to the rest of the industry.
  • In the last couple of years the Gross Margin of JBSS has declined.
Industry RankSector Rank
OM 8.38%
PM (TTM) 5.84%
GM 18.68%
OM growth 3Y-4.93%
OM growth 5Y-3.02%
PM growth 3Y-6.28%
PM growth 5Y-2.84%
GM growth 3Y-4.17%
GM growth 5Y-1.65%
JBSS Yearly Profit, Operating, Gross MarginsJBSS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20

4

2. Health

2.1 Basic Checks

  • JBSS has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
  • Compared to 1 year ago, JBSS has more shares outstanding
  • JBSS has more shares outstanding than it did 5 years ago.
  • JBSS has a worse debt/assets ratio than last year.
JBSS Yearly Shares OutstandingJBSS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M 8M 10M
JBSS Yearly Total Debt VS Total AssetsJBSS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M 500M

2.2 Solvency

  • An Altman-Z score of 5.50 indicates that JBSS is not in any danger for bankruptcy at the moment.
  • JBSS has a Altman-Z score of 5.50. This is amongst the best in the industry. JBSS outperforms 87.36% of its industry peers.
  • JBSS has a Debt/Equity ratio of 0.22. This is a healthy value indicating a solid balance between debt and equity.
  • JBSS's Debt to Equity ratio of 0.22 is fine compared to the rest of the industry. JBSS outperforms 70.11% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.22
Debt/FCF N/A
Altman-Z 5.5
ROIC/WACC1.61
WACC8.66%
JBSS Yearly LT Debt VS Equity VS FCFJBSS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M 200M 300M

2.3 Liquidity

  • JBSS has a Current Ratio of 2.44. This indicates that JBSS is financially healthy and has no problem in meeting its short term obligations.
  • With a decent Current ratio value of 2.44, JBSS is doing good in the industry, outperforming 68.97% of the companies in the same industry.
  • JBSS has a Quick Ratio of 2.44. This is a bad value and indicates that JBSS is not financially healthy enough and could expect problems in meeting its short term obligations.
  • JBSS has a worse Quick ratio (0.72) than 63.22% of its industry peers.
Industry RankSector Rank
Current Ratio 2.44
Quick Ratio 0.72
JBSS Yearly Current Assets VS Current LiabilitesJBSS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M

3

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 20.86% over the past year.
  • The Earnings Per Share has been growing slightly by 1.37% on average over the past years.
  • JBSS shows a small growth in Revenue. In the last year, the Revenue has grown by 1.88%.
  • JBSS shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 4.70% yearly.
EPS 1Y (TTM)20.86%
EPS 3Y-0.91%
EPS 5Y1.37%
EPS Q2Q%59%
Revenue 1Y (TTM)1.88%
Revenue growth 3Y5.02%
Revenue growth 5Y4.7%
Sales Q2Q%8.14%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y20.37%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year5.4%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
JBSS Yearly Revenue VS EstimatesJBSS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 200M 400M 600M 800M 1B
JBSS Yearly EPS VS EstimatesJBSS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2024 2025 2026 2 4 6

5

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 13.08, which indicates a correct valuation of JBSS.
  • JBSS's Price/Earnings ratio is a bit cheaper when compared to the industry. JBSS is cheaper than 74.71% of the companies in the same industry.
  • JBSS's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.38.
  • Based on the Price/Forward Earnings ratio of 12.14, the valuation of JBSS can be described as correct.
  • JBSS's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. JBSS is cheaper than 78.16% of the companies in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 24.29. JBSS is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 13.08
Fwd PE 12.14
JBSS Price Earnings VS Forward Price EarningsJBSS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • JBSS's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. JBSS is cheaper than 77.01% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 7.25
JBSS Per share dataJBSS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60 80

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • JBSS has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)0.64
PEG (5Y)9.57
EPS Next 2YN/A
EPS Next 3YN/A

3

5. Dividend

5.1 Amount

  • JBSS has a Yearly Dividend Yield of 1.21%.
  • JBSS's Dividend Yield is comparable with the industry average which is at 2.28.
  • JBSS's Dividend Yield is slightly below the S&P500 average, which is at 1.85.
Industry RankSector Rank
Dividend Yield 1.21%

5.2 History

  • The dividend of JBSS decreases each year by -19.01%.
  • JBSS has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)-19.01%
Div Incr Years0
Div Non Decr Years0
JBSS Yearly Dividends per shareJBSS Yearly Dividends per shareYearly Dividends per share 2017 2018 2019 2020 2021 2022 2023 2024 2025 1 2 3 4 5

5.3 Sustainability

  • 26.50% of the earnings are spent on dividend by JBSS. This is a low number and sustainable payout ratio.
DP26.5%
EPS Next 2YN/A
EPS Next 3YN/A
JBSS Yearly Income VS Free CF VS DividendJBSS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M -20M 40M 60M 80M 100M
JBSS Dividend Payout.JBSS Dividend Payout, showing the Payout Ratio.JBSS Dividend Payout.PayoutRetained Earnings

JOHN B. SANFILIPPO & SON INC

NASDAQ:JBSS (1/16/2026, 8:00:02 PM)

After market: 73.49 0 (0%)

73.49

-0.99 (-1.33%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)10-29
Earnings (Next)01-27
Inst Owners95.31%
Inst Owner Change-0.06%
Ins Owners1.44%
Ins Owner Change-14.65%
Market Cap855.42M
Revenue(TTM)1.13B
Net Income(TTM)66.00M
Analysts85.71
Price TargetN/A
Short Float %2.56%
Short Ratio2.84
Dividend
Industry RankSector Rank
Dividend Yield 1.21%
Yearly Dividend2.1
Dividend Growth(5Y)-19.01%
DP26.5%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 13.08
Fwd PE 12.14
P/S 0.76
P/FCF N/A
P/OCF 15.92
P/B 2.36
P/tB 2.47
EV/EBITDA 7.25
EPS(TTM)5.62
EY7.65%
EPS(NY)6.05
Fwd EY8.24%
FCF(TTM)-0.85
FCFYN/A
OCF(TTM)4.62
OCFY6.28%
SpS97.06
BVpS31.17
TBVpS29.8
PEG (NY)0.64
PEG (5Y)9.57
Graham Number62.78
Profitability
Industry RankSector Rank
ROA 11.02%
ROE 18.19%
ROCE 20.5%
ROIC 13.93%
ROICexc 13.95%
ROICexgc 14.39%
OM 8.38%
PM (TTM) 5.84%
GM 18.68%
FCFM N/A
ROA(3y)12.11%
ROA(5y)13.03%
ROE(3y)18.85%
ROE(5y)20.67%
ROIC(3y)16.04%
ROIC(5y)17.32%
ROICexc(3y)16.09%
ROICexc(5y)17.36%
ROICexgc(3y)16.85%
ROICexgc(5y)18.29%
ROCE(3y)22.35%
ROCE(5y)24.36%
ROICexgc growth 3Y-10.55%
ROICexgc growth 5Y-7.62%
ROICexc growth 3Y-10.04%
ROICexc growth 5Y-6.93%
OM growth 3Y-4.93%
OM growth 5Y-3.02%
PM growth 3Y-6.28%
PM growth 5Y-2.84%
GM growth 3Y-4.17%
GM growth 5Y-1.65%
F-Score5
Asset Turnover1.89
Health
Industry RankSector Rank
Debt/Equity 0.22
Debt/FCF N/A
Debt/EBITDA 0.67
Cap/Depr 231.27%
Cap/Sales 5.64%
Interest Coverage 250
Cash Conversion 43.96%
Profit Quality N/A
Current Ratio 2.44
Quick Ratio 0.72
Altman-Z 5.5
F-Score5
WACC8.66%
ROIC/WACC1.61
Cap/Depr(3y)134.82%
Cap/Depr(5y)127.89%
Cap/Sales(3y)3.1%
Cap/Sales(5y)2.82%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)20.86%
EPS 3Y-0.91%
EPS 5Y1.37%
EPS Q2Q%59%
EPS Next Y20.37%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)1.88%
Revenue growth 3Y5.02%
Revenue growth 5Y4.7%
Sales Q2Q%8.14%
Revenue Next Year5.4%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y25.64%
EBIT growth 3Y-0.15%
EBIT growth 5Y1.53%
EBIT Next Year58.78%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-110.45%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-53.67%
OCF growth 3Y15.94%
OCF growth 5Y-13.64%

JOHN B. SANFILIPPO & SON INC / JBSS FAQ

What is the ChartMill fundamental rating of JOHN B. SANFILIPPO & SON INC (JBSS) stock?

ChartMill assigns a fundamental rating of 4 / 10 to JBSS.


Can you provide the valuation status for JOHN B. SANFILIPPO & SON INC?

ChartMill assigns a valuation rating of 5 / 10 to JOHN B. SANFILIPPO & SON INC (JBSS). This can be considered as Fairly Valued.


What is the profitability of JBSS stock?

JOHN B. SANFILIPPO & SON INC (JBSS) has a profitability rating of 6 / 10.


Can you provide the PE and PB ratios for JBSS stock?

The Price/Earnings (PE) ratio for JOHN B. SANFILIPPO & SON INC (JBSS) is 13.08 and the Price/Book (PB) ratio is 2.36.


What is the financial health of JOHN B. SANFILIPPO & SON INC (JBSS) stock?

The financial health rating of JOHN B. SANFILIPPO & SON INC (JBSS) is 4 / 10.